DAA885 |
Renal blood flow declines |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA640 |
Renal failure |
Pathological |
kidney |
Human |
— |
SeriesMorbidity |
|
DAA897 |
Response to antidiuretic hormone decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA276 |
Rh family, C glycoprotein |
Molecular |
kidney |
Human |
RHCG |
16.0% Decrease Gene Expression Level |
|
DAA282 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 |
Molecular |
kidney |
Human |
SERPINA5 |
11.0% Decrease Gene Expression Level |
|
DAA898 |
Sodium conservation decreased |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA268 |
solute carrier family 12 (sodium/chloride transporters), member 3 |
Molecular |
kidney |
Human |
SLC12A3 |
16.0% Decrease Gene Expression Level |
|
DAA902 |
specific activities of enzymes are reduced |
Molecular |
kidney |
Human |
— |
— |
|
DAA286 |
StAR-related lipid transfer (START) domain containing 8 |
Molecular |
kidney |
Human |
STARD8 |
14.0% Decrease Gene Expression Level |
|
DAA901 |
telomere shortening |
Molecular |
kidney |
Human |
— |
— |
|
DAA904 |
Transport maximum for glucose declines |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA277 |
tyrosinase-related protein 1 |
Molecular |
kidney |
Human |
TYRP1 |
21.0% Decrease Gene Expression Level |
|
DAA900 |
Urine concentrating capacity decreases |
Physiological |
renal tubule |
Human |
— |
— |
|
DAA896 |
Vasodilation induced by acetylcholine or sodium reduced |
Physiological |
renal vasculature |
Human |
— |
— |
|
DAA884 |
Widespread degeneration of glomerular blood vessels |
Physiological |
renal vasculature |
Human |
— |
— |
|